1.
Seven-year follow-up of infliximab therapy in rheumatoid arthritis patients with severe long-standing refractory disease : attrition rate and evolution of disease activity.
2.
3.
4.
5.
FRI0668 FIRST DATA OF THE TARDIS-RAREGISTRY, A NATIONWIDE BELGIAN BIOLOGIC REGISTRY
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategies
6.
7.
The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry : clues for the optimization of rituximab treatment strategies.
8.
9.